News
Lantheus shares fell 25% post-Q1 2025 report due to disappointing EPS guidance and not meet analysts' expectations. Click ...
President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United States — but why are drugs so high to begin with?
In this week’s edition of InnovationRx, we look at Trump's drug pricing executive order, how the cofounder of Hims became a ...
President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit ...
4hOpinion
WhoWhatWhy on MSNOne Small Thing: Stand Up for Our InstitutionsRight now, we must stand strong against the dismantling of our public libraries and independent local schools. One Small ...
Trump went on to say that his “very rich” friend purchased a weight loss drug, like Ozempic or Wegovy, while in London for $88. He said in the United States, his friend purchased the drug for about $1 ...
UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs ...
The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...
Order expected to affect specific medications covered under Medicare that are administered in a health care setting.
One blue-chip dividend stock from the S&P 500 index has lost nearly half its value in just four weeks. Is it currently 'on ...
9h
DMR News on MSNTrump Announces Executive Order to Cut Drug PricesWell, President Donald Trump has released an audacious proposal. His latest proposal would restart an ambitious policy from ...
President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price negotiations; Vinay Prasad to take the helm at the FDA’s Center for Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results